Haloperidol versus olanzapine for people with schizophrenia
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the clinical effects and safety of haloperidol compared to olanzapine for people with schizophrenia and schizophrenia-like illnesses. © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd